Epigenetic Approaches in Cancer Epidemiology (R21)

The summary for the Epigenetic Approaches in Cancer Epidemiology (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Epigenetic Approaches in Cancer Epidemiology (R21): Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-031 that encourages applications under the NIH research project grants (R01). Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Federal Grant Title:	Epigenetic Approaches in Cancer Epidemiology (R21)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-10-032
Type of Funding:	Grant
CFDA Numbers:	93.399
CFDA Descriptions:	Cancer Control
Current Application Deadline:	Jan 07, 2013
Original Application Deadline:	Jan 07, 2013
Posted Date:	Nov 24, 2009
Creation Date:	Nov 24, 2009
Archive Date:	Feb 07, 2013
Total Program Funding:
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Ca...; • Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...; • Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...; • Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required); • Co-infection and Cancer (R21 Clinical Trial Not Allowed); • Exploratory Grants for Behavioral Research in Cancer Control; • Decision Making in Cancer: Single-Event Decisions; • Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health: • Single Source: National Centralized Repository for Alzheimer's Disease and Related Dementi...; • Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial O...; • Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Acces...; • Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...; • Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...